ProQR Therapeutics NV (PRQR) EUR0.04
Sell:$2.17Buy:$2.27
$0.06
(2.74%)
- This stock can be held in a
Create an alert
Stocks and Shares ISA$0.06
(2.74%)$0.06
(2.74%)Company Information
About this company
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. Main purpose of the Company is advancement of its Axiomer RNA-editing platform technology. That technology uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unaddressed needs. The Company operates research pipeline that contains of RNA Therapy and AX-0810 Cholestatic Diseases (NTCP).
Key people
Key facts
- EPICPRQR
- LocationNetherlands
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINNL0010872495
- Market cap$231.66m
- Employees166
- Shares in issue105.34m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.